Journals / Glokom Katarakt / 2006 / Cilt: 1 - Sayı: 4

Effects of cataract hardness on phaco parameters and complications

Kronik üveitlerde, arka subtenon steroid enjeksiyonunun göz içi basıncına etkisi

Pages
275–278
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean phaco-time in the SC group was 1.7±0.7 minutes, and in the HC group it was 3.0±1.1 minutes; while mean effective phaco-time in the SC group was 22.1±22.1 seconds, in the HC group it was found to be 46.2±24.0 seconds, and these differences were statistically significant (p<0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the effects of cataract hardness on the parameters and complication rates of phacoemulsification surgery.
📊
Key Findings & Data:Materials and Methods: A total of 154 eyes in 154 patients who underwent phacoemulsification surgery under local anesthesia were assigned to one of two groups for the purpose of the study: a soft cataract group (SC) in which cataracts had a hardness of +1 or +2 (51 patients), and a hard cataract group (HC) in which cataracts had a hardness of +3 or +4 (103 patients).
💡
Conclusion & Impact:Mean phaco-time in the SC group was 1.7±0.7 minutes, and in the HC group it was 3.0±1.1 minutes; while mean effective phaco-time in the SC group was 22.1±22.1 seconds, in the HC group it was found to be 46.2±24.0 seconds, and these differences were statistically significant (p<0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Trabekülektomi · İlaç uygulama yolları · Üveit

Abstract

Purpose: To investigate the effects of cataract hardness on the parameters and complication rates of phacoemulsification surgery. Materials and Methods: A total of 154 eyes in 154 patients who underwent phacoemulsification surgery under local anesthesia were assigned to one of two groups for the purpose of the study: a soft cataract group (SC) in which cataracts had a hardness of +1 or +2 (51 patients), and a hard cataract group (HC) in which cataracts had a hardness of +3 or +4 (103 patients). The groups were compared in phacoemulsification parameters (phaco time, phaco power and effective phaco time) and complication rates. Results: Mean age in the SC group was 68.14±9.6 years, and in the HC group it was 71.03±8.9 years. Mean phaco-time in the SC group was 1.7±0.7 minutes, and in the HC group it was 3.0±1.1 minutes; while mean effective phaco-time in the SC group was 22.1±22.1 seconds, in the HC group it was found to be 46.2±24.0 seconds, and these differences were statistically significant (p<0.05). Mean phaco percentage in the SC group was 0.2±0.1, while in the HC group it was found to be 0.2±0.08, and the difference between the two groups was not statistically significant (p>0.05). In both groups a significant correlation was confirmed between cataract hardness and phaco-time (SC group r=0.317, p=0.023; HC group r=0.313, p=0.01). In terms of complications, in the SC group posterior capsule rupture (PCR) was seen in 4 patients (7.8%), and iris injury in 2 patients (3.9%). In the HC group, PCR was seen in 17 patients (16.5%), capsulorhexis discontinuity in 2 patients (1.9%) and iris injury in 1 patient (1%). In the HC group, moderate corneal edema was observed 16 patients (15.5%) and no corneal edema was observed in SC group. Surgical complications were significantly more frequent in the HC group (p<0.05). Conclusion: Increased cataract hardness caused both a lengthening of phaco-time and an increase in complication rate. So it will be more prudent to advise cataract patients to have early operation before cataract hardness reaches a challanging condition.

Özet

Amaç: Daha önce glokom tespit edilmeyen kronik üveitli olgularda, arka subtenon steroid enjeksiyonunun, göz içi basıncına (GİB) olan etkilerinin saptanması. Gereç ve Yöntem: Kırk iki olgunun, arka subtenon triamsinolon asetonid enjeksiyonu (ASTSE) uygulanan 42 gözü prospektif olarak incelendi. ASTSE öncesi ve ASTSE sonrası 1. ve 3. aydaki GİB değerleri, paired student t-test ile istatistiksel olarak analiz edildi. Bulgular: ASTSE öncesi ortalama GİB 11.8±2.7 mmHg (6- 17mmHg) iken, tedavi sonrası 1. ayda 16.5±7.7 mmHg, 3. ayda ise 14.3±4.7 mmHg (7-30 mmHg) olarak saptandı. ASTSE öncesi ve tedavi sonrası 1. ve 3. aydaki GİB değerleri arasındaki farklar, istatistiksel olarak anlamlı bulundu (p<0.00001, p=0.001). Glokom tedavisine yönelik, 4 göze topikal tıbbi tedavi kullanılırken, 3 göze ise mitomisin C’li trabekülektomi uygulandı. Sonuç: Kronik üveitli olgularda ASTSE’nun, geçici GİB artışı veya glokoma sebep olabileceği sonucuna varıldı.

🔖

Cite This Article

ELGİN, K. U., BERKER, N., ÖZDAL, M. P. Ç., ŞİMŞEK, T., BATMAN, A., SOYKAN, E. (2006). Effects of cataract hardness on phaco parameters and complications. Glokom Katarakt, Cilt: 1 - Sayı: 4, 275–278. https://ajindex.com/articles/226735

References (1)

  1. Lightman S.: Use of steroids and immunosuppressive drugs in the management of posterior uveitis. Eye. 1991;5:294-298. 2.Okada AA, Wakabayashi T, Morimura Y, et al.: Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol. 2003;87:968-971. 3.Helm CJ, Holland GN.: The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995;120:55-64. 4. Yoshikawa K, Kotake S, Ichiishi A, et al.: Posterior subtenon inje- ctions of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1995;39:71 -76. 5. Tanner V, Kanski JJ, Frith PA.: Posterior subtenon's triamcinolone injections in the treatment of uveitis. Eye. 1998,12:579-685. 6. Dafflon ML, Tran VT, Guex-Crouser Y, et al.: Posterior subtenon's steroid injections for the treatment of posterior ocular inflammati- on: indications, efficacy and side effects. Graefes Arch Exp Oph- thalmol. 1999;237:289-295. 7. Mueller AJ, Jian G, Banker AS, et al.: The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Am J Ophthalmol. 1998,125:158-163. 8. Levin DS, Han DP, Dev S, et al.: Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced in- traocular pressure elevation. Am J Ophthalmol. 2002; 133:196-202. 9. Thach AB, Dugel PU, Flindall RJ, et al.: A comparison of retro- bulbar versus subtenon's corticosteroid therapy for cystoid ma- cular edema refractory to topical medications. Ophthalmology. 1997;104:2003-2008. 10. Antcliff RJ, Spalton DJ, Stanford MR, et al.: Intravitreal triamci- nolon for uveitic cystoid macular edema: An optical cohorence tomography study. Ophthalmology. 2001;108:765-772. 11. Uçgun Nİ, Yazar Z, Bilgin B, ve ark.: Diabetik retinopati makula ödemi tedavisinde posterior subtenon triamsinolon asetonid en- jeksiyonunun etkinliği. Ret-Vit. 2004;l2:42-44. 12. Uçgun Nİ, Önen M, Fikret CZ, ve ark.: Retina Ven Tıkanıklığına bağlı makula ödemi tedavisinde posterior subtenon triamsinolon asetonid. Ret-Vit. 2004;12:180-183.